MeiraGTx shares jump as Sanofi invests in gene therapy

  • 📰 MarketWatch
  • ⏱ Reading Time:
  • 22 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 12%
  • Publisher: 97%

Business Business Headlines News

Business Business Latest News,Business Business Headlines

Sanofi may use company’s gene regulation technology in immunology, metabolic disease and other conditions

Shares of MeiraGTx Holdings PLC MGTX, -4.88% jumped 14% premarket on Monday after the gene therapy company announced that French drugmaker Sanofi SNY, -19.13% has made a $30 million investment.

MeiraGTx has also been approached by multiple parties with strategic interest in various company assets and is “actively pursuing these options,” the company said in the release. The investment comes a few months after Sanofi expanded an earlier gene-therapy collaboration with Scribe Therapeutics Inc., licensing Scribe’s gene editing technology for development of in vivo therapies, including sickle cell disease.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 3. in BUSİNESS

Business Business Latest News, Business Business Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Biden's 'aggressive' AI order will make firms share some test dataThe executive order goes beyond the voluntary commitments the administration has won from leading companies.
Source: axios - 🏆 302. / 63 Read more »

White House unveils AI executive order, requiring companies to share national security risks with fedsPresident Biden has issued an executive order Monday that contains numerous initiatives aimed at managing the risk of artificial intelligence.
Source: FoxNews - 🏆 9. / 87 Read more »